Mengdi He

Mengdi He

Auto-generated profile, based on publicly available information

Mengdi He

Department of Biomedical Engineering Carnegie Mellon University Pittsburgh Pennsylvania USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2022 in Advanced Healthcare Materials
Verified
Journal Article
Open access
DHDebbie L. L. Ho
Debbie L. L. Ho
SLStacey Lee
Stacey Lee
JDJianyi Du
Jianyi Du
JWJonathan D. Weiss
Jonathan D. Weiss
TTTony Tam
Tony Tam
MSMark A. Skylar‐Scott
Mark A. Skylar‐Scott
Combining the sustainable culture of billions of human cells and the bioprinting of wholly cellular bioinks offers a pathway toward organ‐scale tissue engineering. Traditional 2D culture methods are not inherently scalable due to cost, space, and handling constraints. Here, the suspension culture of human induced pluripotent stem cell‐derived aggregates (hAs) is optimized using an automated 250 mL stirred tank bioreactor system. Cell yield, aggregate morphology, and pluripotency marker expression are maintained over three serial passages in two distinct cell lines. Furthermore, it is demonstrated that the same optimized parameters can be scaled to an automated 1 L stirred tank bioreactor system. This 4‐day culture results in a 16.6‐ to 20.4‐fold expansion of cells, generating approximately 4 billion cells per vessel, while maintaining >94% expression of pluripotency markers. The pluripotent aggregates can be subsequently differentiated into derivatives of the three germ layers, including cardiac aggregates, and vascular, cortical and intestinal organoids. Finally, the aggregates are compacted into a wholly cellular bioink for rheological characterization and 3D bioprinting. The printed hAs are subsequently differentiated into neuronal and vascular tissue. This work demonstrates an optimized suspension culture‐to‐3D bioprinting pipeline that enables a sustainable approach to billion cell‐scale organ engineering.

10 August 2021 in Journal of the Science of Food and Agriculture
Verified
Journal Article
Closed access
PDF file
LRLi Ruan
Li Ruan
Kang WeiKang Wei
Kang Wei
JLJianwu Li
Jianwu Li
MHMengdi He
Mengdi He
LWLiyun Wu
Liyun Wu
HCHao Cheng
Hao Cheng

23 March 2026 in Advanced Electronic Materials
Verified
Journal Article
Open access
PDF file
HKHan Kim
Han Kim
MBMabel Bartlett
Mabel Bartlett
LWLiyang Wang
Liyang Wang
KBKarl Bates
Karl Bates
MHMengdi He
Mengdi He
TCTzahi Cohen‐Karni
Tzahi Cohen‐Karni
Chronic disease arises slowly through complex physiological factors that require continuous monitoring and treatment. Compliant bioelectronics with soft, stretchable, and tissue‐conformal designs allow for in vivo continuous monitoring through electrophysiological, mechanical, and biochemical modalities, while minimizing tissue irritation and immune system response. In this review, we discuss recent progress in material development, device design, and versatile sensing modalities that allow stable long‐term operation in dynamic biological environments. We focus on chronic electrophysiological systems for neural and cardiac recording, mechanical sensing systems for strain and pressure, and electrochemical sensors for molecular biomarkers. In addition, we examine self‐powered bioelectronics based on piezoelectric and triboelectric energy conversion mechanisms that eliminate the requirement for external batteries, whereas multimodal and closed‐loop systems combine sensing with therapeutic feedback. We consider key parameters like material biocompatibility, device flexibility, and long‐term stability that are required for chronic monitoring to maintain stable signal quality over long time periods relevant for clinical recordings. These technologies for compliant bioelectronics enable early disease diagnosis, personalized treatment and continuous intervention for patients, narrowing the gap between laboratory study and routine clinical applications.

21 October 2026 in Acta Biomaterialia
Verified
Journal Article
Open access
SGSamuel Gershanok
Samuel Gershanok
ABAnne Behre
Anne Behre
RJRifeng Jin
Rifeng Jin
SVSofya Vinokurova
Sofya Vinokurova
JBJohn Blount
John Blount
TCTzahi Cohen-Karni
Tzahi Cohen-Karni